|
INADL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.96299984547943E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.72329994718723E-09 |
| Normal-vs-Stage2 |
2.782700E-04 |
| Normal-vs-Stage3 |
4.402100E-04 |
| Normal-vs-Stage4 |
5.563100E-04 |
| Stage1-vs-Stage2 |
4.742000E-01 |
| Stage1-vs-Stage3 |
7.496000E-01 |
| Stage1-vs-Stage4 |
8.480400E-01 |
| Stage2-vs-Stage3 |
8.170200E-01 |
| Stage2-vs-Stage4 |
7.744800E-01 |
| Stage3-vs-Stage4 |
9.536800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.05509997908138E-09 |
| Normal-vs-AfricanAmerican |
3.155199990168E-09 |
| Normal-vs-Asian |
3.326000E-01 |
| Caucasian-vs-AfricanAmerican |
3.764400E-01 |
| Caucasian-vs-Asian |
6.257400E-01 |
| AfricanAmerican-vs-Asian |
5.207000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.41222622274518E-12 |
| Normal-vs-Female |
5.67499999999388E-05 |
| Male-vs-Female |
4.193700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.67146999999757E-05 |
| Normal-vs-Extreme_Weight |
3.15947268347827E-12 |
| Normal-vs-Obese |
1.4529000003094E-08 |
| Normal-vs-Extreme_Obese |
4.477600E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.023600E-01 |
| Normal_Weight-vs-Obese |
8.165400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.795800E-01 |
| Extreme_Weight-vs-Obese |
1.593190E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.089580E-01 |
| Obese-vs-Extreme_Obese |
1.341370E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.358500E-04 |
| Normal-vs-Age(41-60Yrs) |
1.06269999466946E-08 |
| Normal-vs-Age(61-80Yrs) |
2.82599998957522E-09 |
| Normal-vs-Age(81-100Yrs) |
1.64230999999404E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.146600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.371000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.563800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.877200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.459600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.042600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.8061108164602E-12 |
| Normal-VS-Type2 PRCC |
2.13039999999998E-05 |
| Normal-VS-KIRP CIMP |
2.189600E-02 |
| Normal-VS-Unclassified PRCC |
9.35010000535641E-08 |
| Type1 PRCC-VS-Type2 PRCC |
5.906400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.814800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.322800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.448600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.878010E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.294600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.2084000001209E-07 |
| Normal-vs-N1 |
5.602300E-03 |
| Normal-vs-N2 |
3.395600E-02 |
| N0-vs-N1 |
3.897200E-01 |
| N0-vs-N2 |
7.374000E-01 |
| N1-vs-N2 |
9.303600E-01 |
|
|
